June 2, 2023
National Institute of Mental Health (NIMH)
The purpose of this Notice is to outline priorities for providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that experienced significant setbacks as result of the COVID-19 pandemic, which were unable to be resolved with non-monetary options (e.g., modification to the project or re-budgeting to accomplish aims).
The COVID-19 pandemic and mitigation efforts significantly impacted the U.S. and other countries worldwide. As a result, the NIMH recognizes that investigators may be experiencing significant delays and disruptions to their research and training programs.
This NOSI is to inform the research community that the NIMH is extending support for Administrative Supplements to cover unanticipated costs caused by the COVID-19 pandemic or mitigation-related efforts that could not be covered by rebudgeting existing funds. All requests must be within scope of the awarded specific aims of the parent award.
Due to limited resources the NIMH will not fund all requests. Investigators should exhaust other means of overcoming pandemic-related setbacks and should only request NIMH supplemental funding in cases of significant need. Requests for support during the first year of the parent award (new or competing renewals) will not be considered responsive to this NOSI. Likewise, COVID-related research requests (i.e. to add research questions on the SARS-CoV2 virus or broader impacts of the pandemic on mental health) will not be considered under this NOSI and should be directed to NOT-MH-22-100).
NIMH will prioritize requests based on the Institute priorities listed below. Applicants are strongly encouraged to contact the Program Officer of the parent award before submitting a supplement application.
In concert with the NIH priorities, the NIMH aims to prioritize supplement requests in the following order:
Other requests may be considered but will be regarded as a lower priority. Investigators planning to submit supplement applications are strongly encouraged to discuss the proposed project with the relevant NIMH scientific/programmatic contacts before applying to determine eligibility and alignment with the NIMH priorities listed above.
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) is intended to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant.
Application and Submission Information
NIMH accepts and reviews administrative supplement applications on a continuous basis until April 1 of each fiscal year (FY). Administrative supplement applications received after the April 1 submission date will not be considered for funding until the next fiscal year. Earlier submission in the fiscal year is strongly encouraged. Investigators should not apply for a supplement with significant unobligated balance and should apply at the point in the study when it is clear that additional funds are required.
To be eligible, the parent award must be active (not in a no-cost extension) and the research proposed in the supplement must be accomplished within the competitive segment. The proposed project period cannot extend beyond the parent award. NIMH recommends applicants submit as early as possible.
Submit applications for this initiative using the following Notice of Funding Opportunity (NOFO) or any reissue of this announcement through the expiration date of this notice.
All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:
Applicants should direct their inquiries to the program officer of the parent award.